Life Science Executive Partnering
March 10-11, 2026Miami Beach Convention Center, FL, USA Paolo Di GiorgioCEO & Managing Director at Angelini VenturesSpeaker
Profile
Leading Angelini Ventures from 2022 with over 20 years of experience in venture capital, R&D and business development in companies such as Angelini Pharma, Novartis and Merck.
He holds a PhD from Harvard University and an MBA from IE business school.
Currently a board member of Argobio and Extend, an observer board member of Pretzel Therapeutics, Freya, Cour, Nouscom and a member of the investment committee of the Angelini Lumira Bioscience Fund
Paolo Di Giorgio's Network
Agenda Sessions
Global Life Science Investment Pulse Check and How Does the US Measure Up?
, 9:05amView Session